By Joseph Caspermeyer A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. Now, Qingke Kong and his colleagues at the Biodesign Institute at Arizona State University, have developed a technique to make […]
Equality of the sexes? Not always when it comes to biology
‘Man flu’ is real According to Cambridge University researchers, evolutionary factors have led to the male system becoming more vulnerable to illness. Kipnews.org Posted: 28th June 2011 by MaxWild in Health & Nutrition MUHC researchers demonstrate that estrogen renders the innate immune system of women more powerful than that of Men Montreal, May 11, 2009 […]
Human Smears
By Madhavi Tata Poor Andhra villagers now victims of clinical drug trials. No Drug Resistance •35 women, some men from Guntur district put through clinical trials of a breast cancer drug. They later complain of joint pains, nausea and chest pains. •Biotech industry in Andhra is worth about Rs 455 crore (around $100 million) •Touts […]
India: deadly drug trials
By Jason Overdorf A $400 million market for clinical trials puts desperate Indian patients at risk. CHENNAI, India — India’s huge population, many of whom have hardly been exposed to medication, makes it one of the world’s most promising markets for drug research. But as the $400 million business accelerates, critics say it is exposing […]
Large patient pool in India for trials
The Times of India June 18, 2011 Factors such as skilled medical professionals, low-cost services, diverse genetic pool, large patient pool and world-class hospitals to undertake clinical trials are the reason for India becoming a favoured destination for such clinical trials. Andhra Pradesh accounts for almost 28 per cent of total trials in the country. […]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 11
- Next Page »
